Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID07251725

Unravelling the Genetic Basis of Familial Pulmonary Fibrosis: A Next-Generation Sequencing Approach to Fibrogenesis and Surfactant Disorder Genes

Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2025-11-26

126

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Pulmonary fibrosis (PF) is a lung disease that causes scarring and difficulty breathing. Familial pulmonary fibrosis (FPF) accounts for 10-20% of PF cases and shares similarities with idiopathic pulmonary fibrosis (IPF), though the genetic causes of FPF are not fully known. This study aims to explore the genetic factors behind FPF by studying families with multiple affected members, focusing on genes related to tissue scarring and surfactant disorders to better understand early diagnosis, disease progression, and treatment possibilities. This observational, longitudinal retrospective study includes two groups: those with familial pulmonary fibrosis and those with idiopathic pulmonary fibrosis as a comparison group. Researchers will analyze genetic samples using next-generation sequencing to identify genetic variants linked to the disease. Participants will undergo genetic testing, clinical evaluations, and provide family history information, with blood samples collected from affected and unaffected family members for analysis. Participants will be followed over time with ongoing evaluations and genetic testing to track disease progression and outcomes. The main measurement is the number and type of genetic variants found within 24 months of enrollment. The study involves informed consent and includes adults aged 18 and older. Researchers aim to improve genetic counseling, early diagnosis, and potential personalized treatments for both familial and idiopathic forms of pulmonary fibrosis, with study participation lasting at least two years.

CONDITIONS

Brief Title

GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of familial pulmonary fibrosis with at least two first-degree relatives affected
  • Definite or probable familial pulmonary fibrosis diagnosis by international criteria
  • Adults aged 18 years or older at enrollment
  • Ability and willingness to provide written informed consent
  • Willingness to participate in genetic testing, clinical evaluations, and follow-up
  • Availability of affected family members to provide blood samples and clinical information
  • Unaffected first-degree relatives willing to participate in genetic testing and family history documentation
  • Individuals with confirmed idiopathic pulmonary fibrosis enrolled as a comparison group
Not Eligible

You will not qualify if you...

  • Individuals with isolated, sporadic pulmonary fibrosis not part of the idiopathic pulmonary fibrosis control group
  • Presence of other significant pulmonary diseases unrelated to fibrosis (e.g., COPD, asthma, cystic fibrosis, active lung infection)
  • Unwillingness to provide or maintain informed consent for participation, genetic testing, or long-term data use

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Within 24 months of enrollment

Participants undergo genetic testing and clinical evaluations to identify pathogenic variants related to pulmonary fibrosis.

1 to 2 visits depending on genetic testing and clinical evaluation needs

Long-term Monitoring

Duration - Up to 6 years

Participants are followed longitudinally with retrospective data collection to observe disease progression and genetic findings over time.

Visit schedule varies based on clinical care and follow-up requirements

Trial Site Locations

Total: 1 location

1

Fondazione IRCCS Policlinico San Matteo

Pavia, Lombardy, Italy, 27100

Actively Recruiting

Loading map...

Research Team

I

Ilaria Campo, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Double Blind, Randomized, Placebo-controlled Trial of Nera...

Familial Pulmonary Fibrosis

Actively Recruiting

56 locations

Mechanisms of Familial Pulmonary Fibrosis

Familial Pulmonary Fibrosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here